Tumor Necrosis Factor Alpha-Mediated Inflammation and Remodeling of the Extracellular Matrix Underlies Aortic Stiffening Induced by the Common Chemotherapeutic Agent Doxorubicin
Journal Article
Overview
publication date
- May 1, 2021
has subject area
- Aminoglycosides - Doxorubicin
- Animals
- Antineoplastic Agents
- Aorta
- Biological Factors - Tumor Necrosis Factor-alpha
- Biological Factors - Tumor Necrosis Factor-alpha
- Blood Proteins - Tumor Necrosis Factor-alpha
- Extracellular Matrix
- Extracellular Matrix Proteins - Collagen
- Extracellular Matrix Proteins - Elastin
- Hydrocarbons, Aromatic - Doxorubicin
- Inflammation
- Macromolecular Substances - Collagen
- Macromolecular Substances - Elastin
- Male
- Mice
- Peptides - Tumor Necrosis Factor-alpha
- Peptides - Tumor Necrosis Factor-alpha
- Polycyclic Compounds - Doxorubicin
- Proteins - Tumor Necrosis Factor-alpha
- Proteins - Tumor Necrosis Factor-alpha
- Proteins - Tumor Necrosis Factor-alpha
- Pulse Wave Analysis
- Vascular Stiffness
has restriction
- bronze
Date in CU Experts
- May 7, 2021 3:20 AM
Full Author List
- Clayton ZS; Brunt VE; Hutton DA; Casso AG; Ziemba BP; Melov S; Campisi J; Seals DR
author count
- 8
citation count
- 18
published in
- Hypertension Journal
Other Profiles
International Standard Serial Number (ISSN)
- 0194-911X
Electronic International Standard Serial Number (EISSN)
- 1524-4563
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1581
end page
- 1590
volume
- 77
issue
- 5